Complete Blood Count (CBC) in COVID-19 Patients Attending at Bangladesh Institute of Health Sciences (BIHS) General Hospital, Dhaka, Bangladesh
Khaleda Ferdous, Md. Ashiqur Rahman, Sadia Islam, Sadia Tasnim, Tamima Ferdausi, Shohanur Rahaman, Md. Al-Amin Hossen, Adiatuj Jahan Rimu
Journal of Applied Life Sciences International · pp. 27–34 · Published 30 Aug 2023
10.9734/jalsi/2023/v26i5616Abstract
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the infectious agent that causes Coronavirus Disease 2019 (COVID-19), a contagious illness. The epidemic has continued since it was first discovered in Wuhan, Hubei, China, in December 2019. The WHO estimated that 800 million people worldwide (or one in ten) may have COVID-19 infection on October 5. More than 1.07 million fatalities and 37 million cases have been documented as of October 11, 2020, spanning 188 nations and territories; more than 25.7 million patients have recovered. Fever, coughing, exhaustion, shortness of breath or other breathing issues, and a loss of taste and smell are typical symptoms. Acute respiratory distress syndrome (ARDS), which can be brought on by cytokine storm, multi-organ failure, septic shock, and blood clots, can affect some people while the majority only have moderate symptoms. One to fourteen days may pass during the incubation period. The aim of this study was to observe the Complete blood count in COVID-19 & Non COVID-19 Patients in Bangladesh. A descriptive cross-sectional study was conducted for the study. Data were collected from Bangladesh Institute of Health Sciences (BIHS) General Hospital and Hematology Department of Bangladesh University of Health Sciences (BUHS). A pretested semi-structured questionnaire was used for the data collection. The standard method of diagnosis is by real-time reverse transcription polymerase chain reaction (RT-PCR) from a nasopharyngeal swab. The results showed that, among 100 patients, 50% patient was Covid-19 positive &50% patient was negative. In comparison between Covid-19 positive & negative CBC result showing that Hb% remain almost same, total count is slightly increased in covid-19 positive patient than non-covid-19. RBC are found in Normal range for both positive and negative patients. Platelet count & PCV are lower in Covid-19 positive patient than negative patient. Neutrophil are significantly raised in Covid-19 positive patient. Lymphocytes are significantly decreased in Covid-19 positive patient than negative. In this study males are affected 64% & females are 36% so the ratio between male& female is 3:2. More positive patients were found in the age between 50-70 years & has risk among 40-80 years. According to this study, it can be concluded that there is an association among neutrophil, lymphocyte and other cell status in clinically in COVID-19 & non COVID-19 Patients.
References (15)
- 1 Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19 [DOI]
- 2 Mechanism of thrombocytopenia in COVID-19 patients [DOI]
- 3 Epidemiology and clinical features of COVID-19: A review of current literature [DOI]
- 4 Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China [DOI]
- 5 Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters [DOI]
- 6 Role of Hematological Parameters in Covid-19 Patients in the Emergency Room [DOI]
- 7 Changes of hematological and immunological parameters in COVID-19 patients [DOI]
- 8 Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection [DOI]
- 9 A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients [DOI]
- 10 Association between red blood cell distribution width and mortality and severity among patients with COVID‐19: A systematic review and meta‐analysis [DOI]
- 11 Red blood cell morphology in patients with COVID-19-related anaemia. [DOI]
- 12 Public Health Problems in Bangladesh: Issues and challenges [DOI]
- 13 Health service facilities are positively linked with outcome of COVID-19 patients in majority of the countries: The global situation [DOI]
- 14 Cigarette smoking and COVID-19 [DOI]
- 15 Clinical, Laboratory and Imaging Features of COVID-19: A Systematic Review and Meta-analysis [DOI]
Cited by 0
No indexed citations yet.
Related research
- Covid-2019:“A Microbiological Monster” — shares topic coverage
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia — shares topic coverage
Article metrics
Real usage data collected on this platform.
37
Page views
0
PDF downloads
13
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.